Key facts
- NoBACZ Healthcare’s last known valuation is $14.8M (Sep 2025).
- It has raised $11.3M; the latest was Later Stage VC ($6.5M) in Sep 2025.
- Notable investors include Innovate UK, The FSE Group, Parkwalk Advisors, Cambridge Angels, Cambridge Enterprise Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for NoBACZ Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for NoBACZ Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NoBACZ Healthcare
Developer of a precision bandage technology designed to improve wound care management. The company's tool specializes in creating rapid-set liquid barriers as wound care products are sterile, antimicrobial, and biodegradable, and can be tailored to suit any wound type, enabling doctors to treat deep wounds in antibiotic use on the farm and in veterinary practice without worrying about subsequent infections resulting from the bandages.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2019
- Employees
- 25
- Website
- nobacz.com/
- Ownership
- Privately Held (backing)
NoBACZ Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NoBACZ Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NoBACZ Healthcare in its N-PORT filings yet. We sweep new filings monthly.